12
views
0
recommends
+1 Recommend
2 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      SARS-CoV-2 infection of human iPSC-derived cardiac cells reflects cytopathic features in hearts of patients with COVID-19

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Although coronavirus disease 2019 (COVID-19) causes cardiac dysfunction in up to 25% of patients, its pathogenesis remains unclear. Exposure of human induced pluripotent stem cell (iPSC)-derived heart cells to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) revealed productive infection and robust transcriptomic and morphological signatures of damage, particularly in cardiomyocytes. Transcriptomic disruption of structural genes corroborates adverse morphologic features, which included a distinct pattern of myofibrillar fragmentation and nuclear disruption. Human autopsy specimens from patients with COVID-19 reflected similar alterations, particularly sarcomeric fragmentation. These striking cytopathic features in cardiomyocytes provide insights into SARS-CoV-2-induced cardiac damage, offer a platform for discovery of potential therapeutics, and raise concerns about the long-term consequences of COVID-19 in asymptomatic as well as severe cases.

          Abstract

          Infection of human iPSC-derived cardiomyocytes by SARS-CoV-2 leads to specific cytopathic features reflected in patient autopsy samples.

          Related collections

          Most cited references80

          • Record: found
          • Abstract: found
          • Article: not found

          Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

          Summary Background Since December, 2019, Wuhan, China, has experienced an outbreak of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Epidemiological and clinical characteristics of patients with COVID-19 have been reported but risk factors for mortality and a detailed clinical course of illness, including viral shedding, have not been well described. Methods In this retrospective, multicentre cohort study, we included all adult inpatients (≥18 years old) with laboratory-confirmed COVID-19 from Jinyintan Hospital and Wuhan Pulmonary Hospital (Wuhan, China) who had been discharged or had died by Jan 31, 2020. Demographic, clinical, treatment, and laboratory data, including serial samples for viral RNA detection, were extracted from electronic medical records and compared between survivors and non-survivors. We used univariable and multivariable logistic regression methods to explore the risk factors associated with in-hospital death. Findings 191 patients (135 from Jinyintan Hospital and 56 from Wuhan Pulmonary Hospital) were included in this study, of whom 137 were discharged and 54 died in hospital. 91 (48%) patients had a comorbidity, with hypertension being the most common (58 [30%] patients), followed by diabetes (36 [19%] patients) and coronary heart disease (15 [8%] patients). Multivariable regression showed increasing odds of in-hospital death associated with older age (odds ratio 1·10, 95% CI 1·03–1·17, per year increase; p=0·0043), higher Sequential Organ Failure Assessment (SOFA) score (5·65, 2·61–12·23; p<0·0001), and d-dimer greater than 1 μg/mL (18·42, 2·64–128·55; p=0·0033) on admission. Median duration of viral shedding was 20·0 days (IQR 17·0–24·0) in survivors, but SARS-CoV-2 was detectable until death in non-survivors. The longest observed duration of viral shedding in survivors was 37 days. Interpretation The potential risk factors of older age, high SOFA score, and d-dimer greater than 1 μg/mL could help clinicians to identify patients with poor prognosis at an early stage. Prolonged viral shedding provides the rationale for a strategy of isolation of infected patients and optimal antiviral interventions in the future. Funding Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences; National Science Grant for Distinguished Young Scholars; National Key Research and Development Program of China; The Beijing Science and Technology Project; and Major Projects of National Science and Technology on New Drug Creation and Development.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            clusterProfiler: an R package for comparing biological themes among gene clusters.

            Increasing quantitative data generated from transcriptomics and proteomics require integrative strategies for analysis. Here, we present an R package, clusterProfiler that automates the process of biological-term classification and the enrichment analysis of gene clusters. The analysis module and visualization module were combined into a reusable workflow. Currently, clusterProfiler supports three species, including humans, mice, and yeast. Methods provided in this package can be easily extended to other species and ontologies. The clusterProfiler package is released under Artistic-2.0 License within Bioconductor project. The source code and vignette are freely available at http://bioconductor.org/packages/release/bioc/html/clusterProfiler.html.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Cytoscape: a software environment for integrated models of biomolecular interaction networks.

              Cytoscape is an open source software project for integrating biomolecular interaction networks with high-throughput expression data and other molecular states into a unified conceptual framework. Although applicable to any system of molecular components and interactions, Cytoscape is most powerful when used in conjunction with large databases of protein-protein, protein-DNA, and genetic interactions that are increasingly available for humans and model organisms. Cytoscape's software Core provides basic functionality to layout and query the network; to visually integrate the network with expression profiles, phenotypes, and other molecular states; and to link the network to databases of functional annotations. The Core is extensible through a straightforward plug-in architecture, allowing rapid development of additional computational analyses and features. Several case studies of Cytoscape plug-ins are surveyed, including a search for interaction pathways correlating with changes in gene expression, a study of protein complexes involved in cellular recovery to DNA damage, inference of a combined physical/functional interaction network for Halobacterium, and an interface to detailed stochastic/kinetic gene regulatory models.
                Bookmark

                Author and article information

                Journal
                Sci Transl Med
                Sci Transl Med
                STM
                Science Translational Medicine
                American Association for the Advancement of Science
                1946-6234
                1946-6242
                15 March 2021
                : eabf7872
                Affiliations
                [1 ]Gladstone Institutes, San Francisco, CA 94158, USA.
                [2 ]Biomedical Sciences PhD Program, University of California, San Francisco, CA 94158, USA.
                [3 ]UC Berkeley UCSF Joint Program in Bioengineering, Berkeley, CA 94720, USA.
                [4 ]UCSF Department of Neurology, San Francisco, CA 94143, USA.
                [5 ]UCSF Department of Laboratory Medicine, San Francisco, CA 94143, USA.
                [6 ]University of British Columbia Department of Pathology & Laboratory Medicine, Vancouver, B.C. V6Z 1Y6, Canada.
                [7 ]Innovative Genomics Institute, Berkeley, CA 94704, USA.
                [8 ]UCSF Department of Ophthalmology, San Francisco, CA 94158, USA.
                [9 ]UCSF Department of Medicine, San Francisco, CA 94143, USA.
                [10 ]UCSF Department of Bioengineering and Therapeutic Sciences, San Francisco, CA 94158, USA.
                Author notes
                [*]

                These authors contributed equally to this work.

                Author information
                https://orcid.org/0000-0001-7625-358X
                https://orcid.org/0000-0002-7316-778X
                https://orcid.org/0000-0002-2869-0221
                https://orcid.org/0000-0001-9222-8130
                https://orcid.org/0000-0001-9941-9538
                https://orcid.org/0000-0002-7506-2711
                https://orcid.org/0000-0001-5900-3490
                https://orcid.org/0000-0002-6710-1506
                https://orcid.org/0000-0002-4469-3705
                https://orcid.org/0000-0002-7639-2325
                https://orcid.org/0000-0002-9192-182X
                https://orcid.org/0000-0002-3502-5799
                https://orcid.org/0000-0002-0655-4843
                https://orcid.org/0000-0002-5697-1274
                https://orcid.org/0000-0003-1463-6061
                https://orcid.org/0000-0002-8905-4931
                Article
                abf7872
                10.1126/scitranslmed.abf7872
                8128284
                33723017
                cecf4bca-d0e8-443f-9211-ed23c2972bbb
                Copyright © 2021, American Association for the Advancement of Science

                This is an open-access article distributed under the terms of the Creative Commons Attribution license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 20 November 2020
                : 10 March 2021
                : 15 March 2021
                Funding
                Funded by: doi http://dx.doi.org/10.13039/501100000781, European Research Council;
                Award ID: 20POST35211143
                Funded by: doi http://dx.doi.org/10.13039/501100000781, European Research Council;
                Award ID: NIH 1R01AG065428
                Funded by: doi http://dx.doi.org/10.13039/501100000781, European Research Council;
                Award ID: NIH 5DP1DA038043
                Funded by: doi http://dx.doi.org/10.13039/501100000781, European Research Council;
                Award ID: R01-HL130533
                Funded by: doi http://dx.doi.org/10.13039/501100000781, European Research Council;
                Award ID: R01-HL135358
                Funded by: doi http://dx.doi.org/10.13039/501100000781, European Research Council;
                Award ID: P01-HL146366
                Funded by: FUNDING;
                Funded by: doi http://dx.doi.org/10.13039/501100000781, European Research Council;
                Award ID: 1648035
                Funded by: doi http://dx.doi.org/10.13039/501100000781, European Research Council;
                Award ID: NIH U01 ES032673
                Categories
                Reports
                Reports
                STM reports
                Coronavirus

                Comments

                Comment on this article